Global Commercial Drug Development Consultancy
When it comes to commercial drug development, we support our clients by gathering insight to answer what we see as our core questions. With these answers we help to build and implement strategy that takes into consideration the opportunities and risks of your compounds while maximizing value.
Our core questions answered are:
- What is the SOC in the geography/territory of interest?
- What does the current and future Competitive Environment look like?
- Where does your compound fit with Payers, HCPs, Regs?
- What are the opportunities for the compound and what risk do they bring?
- What value do these opportunities bring?
Where do we support clients? Where do we answer our core questions?
We support clients in the commercial drug development phases specializing in the following areas.
To find out more about each of our services and what they can include, please get in touch with us.
We support clients in the commercial drug development phases specializing in the following areas.
- Pricing and Market Access Strategy: Price and Access underpins all strategic decision making. Pricing can heavily impact sales and costs. Mirador's pricing services include: analogue identification, pricing/reimbursement scans, and therapy treatment cost analysis. Our services can extend to validation for input to strategic assessment
- Drug Development: We support clients by drawing together the information and insight needed to generate data for their approvals, payer acceptance, and uptake in their key territories. With this information we can develop strategic pathways best suited to your compounds. This can involve (but isn't limited to) Gap analysis, Epi work, Forecasting, and Validation.
- BD and Transactions: Mirador's analysis and insight supports assessment of out-licence strategy of partners and/or in-licence assessment. This insight can highlight any challenges from a commercial perspective and support strategy development for commercialization of a compound. Validation can be gained through our Payer network and/or Health Care Professionals.
- Commercialization and Launch Readiness: Helping clients build their strategy that links to investment decisions during Development, Launch Readiness and Commercialisation, supporting understanding of the opportunities and risks. Our strategic advice can be linked to our analysis work in drug development, BD and transactions, forecasting, and insight.
- Compound Forecasting and Valuation: Forecasting can be used in drug development, BD and transactions, or commercialization. Our offering includes Epidemiology and/or Sales Forecasting, Scenario’s and Sensitivities all tied to experienced insight and strategic pathways.
To find out more about each of our services and what they can include, please get in touch with us.
Our Analytical Models and Tools
At Mirador Analytics we look at existing processes within the pharma industry and explore how we can optimize them through the use of analytical tools and frameworks with visuals that give a clear view of their environment.
Working with clients we can build bespoke custom models tailored to your specific needs. Whether you are looking to optimize an existing solution or need help designing and building one, we can offer various levels of support to produce the best outcome.
Contact us to arrange a discussion about bespoke modelling options.
Working with clients we can build bespoke custom models tailored to your specific needs. Whether you are looking to optimize an existing solution or need help designing and building one, we can offer various levels of support to produce the best outcome.
Contact us to arrange a discussion about bespoke modelling options.
